Announced Wed, 30 Sept, 2026 · 17:16 IST

Trading Window Closed for Half-Yearly Results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹1.53

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+0.6% vs market

Trading & Distributors peers, median of 136sector-0.4%-0.2% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.2 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-1.3+0.6-0.4-0.2

Next day

—-1.3—-1.0—

-3.9+0.0-3.9-0.7-3.2

+3.9-0.2+4.1-1.3+5.3

+7.2-3.0+10.2-3.2+10.4

+7.2-2.7+9.9-3.2+10.4

+7.2-1.7+8.9-2.7+9.9

15d

+15.7-8.9+24.6-6.2+21.8

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 136Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Evoq Remedies has closed its trading window from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the half year ended September 30, 2026. The closure applies to all directors, promoters, designated persons and insiders, as required under SEBI insider trading regulations. The intimation is signed by Resolution Professional Dipti Mundra, indicating the company is under CIRP.

Likely market impact

Insiders cannot buy or sell shares until 48 hours after H1 FY27 unaudited results are published.